Altrinsic Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-190,816
| Closed | -$8.83M | – | 46 |
|
|
2025
Q2 | $8.83M | Sell |
190,816
-5,107
| -3% | -$251K | 0.32% | 31 |
|
|
2025
Q1 | $11.9M | Sell |
195,923
-13,186
| -6% | -$769K | 0.59% | 26 |
|
|
2024
Q4 | $11.8M | Sell |
209,109
-68,161
| -25% | -$3.81M | 0.57% | 28 |
|
|
2024
Q3 | $14.3M | Sell |
277,270
-7,718
| -3% | -$362K | 0.61% | 22 |
|
|
2024
Q2 | $11.8M | Sell |
284,988
-11,659
| -4% | -$522K | 0.53% | 24 |
|
|
2024
Q1 | $16.1M | Sell |
296,647
-19,457
| -6% | -$991K | 0.73% | 17 |
|
|
2023
Q4 | $16.2M | Sell |
316,104
-125,893
| -28% | -$6.61M | 0.69% | 21 |
|
|
2023
Q3 | $25.7M | Sell |
441,997
-20,731
| -4% | -$1.27M | 0.99% | 20 |
|
|
2023
Q2 | $29.6M | Buy |
462,728
+40,278
| +10% | +$2.7M | 1.13% | 17 |
|
|
2023
Q1 | $29.3M | Buy |
422,450
+1,072
| +0.3% | +$75.6K | 1.13% | 18 |
|
|
2022
Q4 | $30.3M | Sell |
421,378
-27,673
| -6% | -$2.09M | 1.29% | 16 |
|
|
2022
Q3 | $31.9M | Sell |
449,051
-63,640
| -12% | -$4.62M | 1.47% | 16 |
|
|
2022
Q2 | $39.5M | Sell |
512,691
-54,004
| -10% | -$4.11M | 1.6% | 15 |
|
|
2022
Q1 | $41.4M | Sell |
566,695
-216,092
| -28% | -$14.5M | 1.45% | 15 |
|
|
2021
Q4 | $48.8M | Buy |
782,787
+45,002
| +6% | +$2.64M | 1.56% | 17 |
|
|
2021
Q3 | $43.7M | Sell |
737,785
-24,409
| -3% | -$1.61M | 1.31% | 20 |
|
|
2021
Q2 | $50.9M | Sell |
762,194
-12,033
| -2% | -$785K | 1.55% | 18 |
|
|
2021
Q1 | $48.9M | Sell |
774,227
-13,871
| -2% | -$863K | 1.54% | 20 |
|
|
2020
Q4 | $48.9M | Buy |
788,098
+85,428
| +12% | +$5.25M | 1.66% | 19 |
|
|
2020
Q3 | $42.4M | Buy |
702,670
+8,827
| +1% | +$531K | 1.74% | 17 |
|
|
2020
Q2 | $40.8M | Sell |
693,843
-16,928
| -2% | -$1.01M | 1.78% | 19 |
|
|
2020
Q1 | $39.6M | Sell |
710,771
-96,646
| -12% | -$5.91M | 2.18% | 13 |
|
|
2019
Q4 | $51.8M | Sell |
807,417
-227,333
| -22% | -$13M | 2.18% | 15 |
|
|
2019
Q3 | $52.5M | Buy |
1,034,750
+119,396
| +13% | +$5.61M | 2.27% | 14 |
|
|
2019
Q2 | $41.5M | Buy |
915,354
+26,373
| +3% | +$1.23M | 1.92% | 14 |
|
|
2019
Q1 | $42.4M | Buy |
888,981
+347,173
| +64% | +$17.3M | 1.96% | 15 |
|
|
2018
Q4 | $28.2M | Buy |
541,808
+524,858
| +3,097% | +$28.2M | 1.35% | 25 |
|
|
2018
Q3 | $1.05M | Hold |
16,950
| – | – | 0.05% | 73 |
|
|
2018
Q2 | $938K | Buy |
16,950
+9,504
| +128% | +$513K | 0.04% | 74 |
|
|
2018
Q1 | $471K | Hold |
7,446
| – | – | 0.02% | 82 |
|
|
2017
Q4 | $456K | Buy |
7,446
+443
| +6% | +$27.7K | 0.02% | 82 |
|
|
2017
Q3 | $446K | Sell |
7,003
-350,592
| -98% | -$20.5M | 0.02% | 84 |
|
|
2017
Q2 | $19.9M | Sell |
357,595
-87,642
| -20% | -$4.77M | 0.72% | 43 |
|
|
2017
Q1 | $24.2M | Buy |
+445,237
| New | +$24.4M | 0.82% | 37 |
|
Other funds holding BMY
Altrinsic Global Advisors's BMY Position: Q3 2025 in Review
Altrinsic Global Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 190,816 shares — an estimated $8.83M sold.
Altrinsic Global Advisors first reported a position in BMY in Q1 2017 and held it in 34 quarters. The position peaked at $52.5M in Q3 2019. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Altrinsic Global Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
- Altrinsic Global Advisors sold 190,816 Bristol-Myers Squibb shares in Q3 2025, an estimated $8.83M.
- Altrinsic Global Advisors first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 34 quarters.
- Altrinsic Global Advisors's Bristol-Myers Squibb position peaked at $52.5M in Q3 2019.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Altrinsic Global Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.